CA999851A - Therapeutically useful polypeptides - Google Patents

Therapeutically useful polypeptides

Info

Publication number
CA999851A
CA999851A CA129,894A CA129894A CA999851A CA 999851 A CA999851 A CA 999851A CA 129894 A CA129894 A CA 129894A CA 999851 A CA999851 A CA 999851A
Authority
CA
Canada
Prior art keywords
therapeutically useful
useful polypeptides
polypeptides
therapeutically
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA129,894A
Other versions
CA129894S (en
Inventor
Victor A. Najjar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Application granted granted Critical
Publication of CA999851A publication Critical patent/CA999851A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
CA129,894A 1970-12-16 1971-12-10 Therapeutically useful polypeptides Expired CA999851A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9889070A 1970-12-16 1970-12-16

Publications (1)

Publication Number Publication Date
CA999851A true CA999851A (en) 1976-11-16

Family

ID=22271422

Family Applications (1)

Application Number Title Priority Date Filing Date
CA129,894A Expired CA999851A (en) 1970-12-16 1971-12-10 Therapeutically useful polypeptides

Country Status (7)

Country Link
US (1) US3778426A (en)
JP (1) JPS6053040B1 (en)
CA (1) CA999851A (en)
CH (1) CH605672A5 (en)
DE (1) DE2124003C2 (en)
FR (1) FR2118134B1 (en)
GB (1) GB1364497A (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966701A (en) * 1973-11-07 1976-06-29 The Dow Chemical Company Fibrinogen peptide derivatives
US4001199A (en) * 1974-03-26 1977-01-04 Takeda Chemical Industries, Ltd. Novel polypeptides useful for treating diabetes and hypercholesteremia
US4073890A (en) * 1974-03-26 1978-02-14 Takeda Chemical Industries, Ltd. Novel polypeptides
US4016259A (en) * 1974-07-26 1977-04-05 Research Corporation Contraceptive polypeptides
SE407058B (en) * 1974-12-05 1979-03-12 Kabi Ab NEW CHROMOGENA ENZYME SUBSTRATE FOR SERINE PROTEASES
DE2602443A1 (en) * 1975-04-04 1976-10-21 Univ California BIOLOGICALLY ACTIVE POLYPEPTIDES
US4061625A (en) * 1975-07-11 1977-12-06 Ab Kabi Novel chromogenic thrombin substrates
US4169015A (en) * 1975-07-11 1979-09-25 Ab Kabi Novel chromogenic thrombin substrates
US4181717A (en) * 1978-09-07 1980-01-01 Research Corporation Ovulation enhancing peptides
IT8021120A0 (en) * 1979-04-02 1980-04-01 Inst Organicheskogo Sinteza Ak CYCLIC ANALOGUE OF THE NATURAL PEPTIDE THAT STIMULATES PHAGOCYTOSIS: THREONYL-CYCLE (N-LYSYL-PROLYL-ARGINYL).
US4683292A (en) * 1983-08-12 1987-07-28 Immunetech, Inc. Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors
US4752601A (en) * 1983-08-12 1988-06-21 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin FC receptors
US4585757A (en) * 1984-07-27 1986-04-29 Texas Tech University Health Sciences Center Hypotensive active peptides
IT1188646B (en) * 1986-04-09 1988-01-20 Ellem Ind Farmaceutica TRIPEPTIDE WITH IMMUNOSTIMULANT ACTIVITY
IL89770A (en) * 1988-03-28 1994-12-29 British Tech Group Analgesic peptides and pharmaceutical compositions containing them and the process for the preparation of some such compounds
GB8807427D0 (en) * 1988-03-28 1988-05-05 National Biological Standards Board Peptides
IT1230712B (en) * 1989-02-10 1991-10-29 Sclavo Spa COMPOSITION FOR VACCINES
US5028593A (en) * 1989-08-15 1991-07-02 Board Of Regents, The University Of Texas System Tuftsin analogs
IT1232311B (en) * 1989-09-04 1992-01-28 Sclavo Spa PURIFICATION METHOD OF LOW MOLECULAR PEPTIDIC OR PSEUDO PEPTIDIC STRUCTURE COMPOUNDS.
GB9211668D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
US7666996B2 (en) * 2000-03-01 2010-02-23 Peptera Pharmaceuticals Ltd Casein derived peptides and uses thereof
JP2005511499A (en) * 2001-08-30 2005-04-28 チャイ １３ メディカル リサーチ グループ エヌ． ヴイ． Casein-derived peptide and its medical use
EP2187943A2 (en) * 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent
RU2507212C3 (en) * 2012-03-28 2022-05-04 Общество С Ограниченной Ответственностью "Айвикс" METHOD FOR PRODUCING RECOMBINANT PEPTIDE AND PRODUCED PEPTIDE
JP6552960B2 (en) * 2013-05-28 2019-07-31 アイビックス・リミテッドＩｖｉｘ Ｌｔｄ． Methods for producing recombinant peptides and resulting peptides
RU2626002C1 (en) 2016-10-24 2017-07-21 Общество С Ограниченной Ответственностью "Айвикс" New group of peptides for treatment of female sexual dysfunction
JP2018118973A (en) * 2018-02-23 2018-08-02 アイビックス・リミテッドＩｖｉｘ Ｌｔｄ． Method for producing recombinant peptide and resultant peptide

Also Published As

Publication number Publication date
JPS6053040B1 (en) 1985-11-22
FR2118134B1 (en) 1975-10-10
CH605672A5 (en) 1978-10-13
US3778426A (en) 1973-12-11
DE2124003C2 (en) 1982-04-22
FR2118134A1 (en) 1972-07-28
GB1364497A (en) 1974-08-21
DE2124003A1 (en) 1972-06-22

Similar Documents

Publication Publication Date Title
CA999851A (en) Therapeutically useful polypeptides
CA956225A (en) Insulating materials
CA949251A (en) Hand covering
CA975264A (en) Comminutor-mixer
CA959227A (en) Sphere-dome construction
CA980601A (en) Filament-rotor structures
CA1014551A (en) Synthetic polypeptides
AU3557171A (en) Squeeze-mop
CA988243A (en) Insulating materials
CA940928A (en) Halopyrazoles
CA949410A (en) Carburetter
CA946376A (en) Polypeptides
AU7735181A (en) Peptide
AU442598B2 (en) Roof extension means
AU468508B2 (en) Mast-holder
CA852209A (en) Polypeptide
CA831497A (en) Polypeptide materials
CA839638A (en) Bricks
AU453433B2 (en) Ceramicware kiln
CA848058A (en) Kiln
AU418604B2 (en) Swimmingpool construction
CA959228A (en) Sphere-dome construction
CA844460A (en) Joint structure
CA858335A (en) Tab-opening can
CA857730A (en) Structures